Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Nutrition Related Cancer 1Neoplasms 1Cardiovascular Diseases 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Chocolate × Clear all
NCT02422745 2025-09-24

COSMOS

Brigham and Women's Hospital

Phase 4 Completed
21,442 enrolled 31 charts

Cardiovascular Diseases, Neoplasms

NCT04367493 2020-04-29

Effects of Chocolate Consumption in Elderly Patients With Cancer in Palliative Care

University of Sao Paulo

Phase NA Completed
45 enrolled

Nutrition Related Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡